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Abstract 
Background: Diarrhea is one of the main causes of morbidity and mortality among children less than 5 years of age 
worldwide, and its causes vary by region. This study aimed to determine the etiologic spectrum, prevalent charac-
teristics and antimicrobial resistance patterns of common enteropathogenic bacteria from diarrheagenic children in 
Beijing, the capital of China.
Methods: Stool samples were collected from 2524 outpatients who were aged 0–5 years in Beijing, China during 
2010–2014. Microbiological methods, real-time PCR and antimicrobial susceptibility test were used to identify the 
bacterial causes and antimicrobial resistance patterns in the isolates.
Results: Of the 2524 patients screened, we identified the causes of 269 cases (10.7 %) as follows: diarrheagenic 
Escherichia coli (4.6 %), Salmonella (4.3 %), Shigella (1.4 %) and Vibrio parahaemolyticus (0.4 %). Atypical EPEC, Sal-
monella enteritidis, Shigella sonnei and serotype O3:K6 were the most common serogroups or serotypes of the four 
etiological bacteria. The prevalence of pathogens was correlated with age, season and clinical symptoms. The highest 
proportion of all causative bacteria was found in children aged 3–5 years and in summer. The clinical symptoms asso-
ciated with specific bacterial infection, such as fever; abdominal pain; vomiting; and watery, mucus, and bloody stool, 
were observed frequently in diarrheal patients. Salmonella showed moderate rates of resistance (40–60 %) to ampi-
cillin, nalidixic acid, streptomycin and sulfisoxazole. Resistance to at least three antimicrobials was found in 50 % of 
isolates. Of the top three serotypes in Salmonella, high-level antimicrobial resistance to single and multiple antibiotics 
was more common among Salmonella typhimurium and Salmonella 1, 4, [5], 12:i:- than among S. enteritidis. More than 
90 % of Shigella isolates showed more alarming resistance to most antibiotics, with a widened spectrum compared to 
Salmonella.
Conclusion: Constant antibiotic surveillance is warranted because the bacteria were highly resistant to various 
antimicrobials. Our study contributes to the strengthening of the existing surveillance system and provides aid for 
effective prevention and control strategies for childhood diarrhea.
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Background
Diarrheal disease continues to be one of the foremost 
public health issues worldwide, with more than 1.5 mil-
lion deaths each year, mostly in children under 5  years 
of age in industrializing countries. The average diarrheal 
disease incidence is an average of 2–3 episodes per child 
per year [1, 2]. In China, approximately 40,000 children 
suffer from diarrhea annually, especially during the first 
2  years of life, and China remains one of the highest 
incidence countries [3]. Although diarrhea-associated 
mortality has roughly halved in the past 20  years, there 
is no indication that disease morbidity has decreased [4]. 
Moreover, there has been an alarming increase in the rate 
of resistance to commonly used antimicrobials. There-
fore, acute diarrhea represents an important childhood 
ailment requiring treatment and prevention in China.
Recently, several specific diarrhea surveillance projects 
were conducted to explore the prevalence and etiology of 
bacterial infectious diseases in different regions in China 
[5–7]. Starting in April 2010, we established a real-time 
web-based diarrheal disease surveillance system based 
on sentinel hospitals for an unselected population of out-
patients, which focused on common enteropathogenic 
bacteria accompanying clinical features, epidemiologi-
cal information and laboratory confirmation in Beijing, 
China [8]. Through 5-year surveillance efforts and data 
accumulation, we aimed to identify the prevalence of the 
etiological spectrum, temporal distribution and antibi-




From April 2010 to December 2014, 2524 stool speci-
mens from outpatient children aged 0–5  years with 
acute diarrhea were collected and tested for bacterial 
pathogens. The outpatients comprised 1616 males and 
908 females (male:female ratio  =  1.8:1 and mean age 
1.2  ±  1.1  years). Male children had a higher diarrheal 
incidence than female children, which was similar to the 
findings of other studies, despite the unknown explana-
tion [9–11]. The age distribution showed that more than 
90  % of children suffering from diarrhea were less than 
2 years old (n = 2341, 92.7 %), and prevalence progres-
sively decreased as age increased, in agreement with 
previous studies [11, 12]. This difference in prevalence 
may be due to the gradual reduction in protective anti-
bodies from the mother before the children have devel-
oped mature nervous and immune response against 
various infections [13]. Childhood acute diarrhea was 
more frequent in the summer than in other seasons. Of 
the 2524 enrolled subjects with an average frequency of 
diarrhea of 4.9 ± 2.4, 68.3 % presented with mucus stool, 
30.0 % with watery stool and 2.5 % with bloody stool. The 
other clinical symptoms were not obvious, such as fever, 
accounting for 7.2  % of the total, vomiting (6.5  %) and 
abdominal pain (4.4 %). However, 20.1 % of the diarrheal 
children had a history of antibiotic use prior to admission 
(Table 1).
Distribution of pathogenic bacteria by species 
and serotype
At least one enteric pathogenic bacteria was isolated 
from 269 (10.7  %) of the 2524 stool specimens, with a 
total of 274 isolates. The prevalence of different bacteria 
is shown in Table 2. Diarrheagenic Escherichia coli (DEC) 
was the most common pathogen, isolated in 118 speci-
mens (43.1  %, 118/274), followed by Salmonella in 109 
(39.8 %), Shigella in 37 (13.5 %) and Vibrio parahaemolyt-
icus in 10 (3.6 %). Among samples containing pathogenic 
bacteria (n  =  269), single infections were observed in 
264 (99.1 %) cases, and the remaining five cases of mixed 
infections had two pathogens, including DEC and Sal-
monella (n = 3), DEC and Shigella (n = 1), enteropatho-
genic E. coli (EPEC) and enteroaggregative E. coli (EAEC) 
(n = 1).
The prevalence pattern of serogroup and serotype by 
region is diverse in different studies. DEC is an important 
etiologic agent of diarrhea in developing countries [14]. 
In this study, 118 DEC isolates were detected from nine 
virulence genes. The most prevalent category was EPEC, 
followed by EAEC, enterotoxigenic E. coli (ETEC), enter-
oinvasive E. coli (EIEC), and Shiga toxin-producing E. 
coli (STEC). Among the 67 EPEC strains, 58 strains car-
rying the eae gene only were grouped as atypical EPEC, 
and the other nine strains harboring the bfpA and eae 
genes were typical EPEC. The atypical EPEC were more 
prevalent than typical EPEC (49.2 vs. 7.6 %), which is an 
emerging trend in developing and developed countries 
[15, 16]. Although the etiologic role of this sub-pathotype 
of EPEC in diarrhea has not been definitively established 
[17], this finding underscores the emergence of atypical 
EPEC worldwide. EAEC (23.7  %) was the second most 
abundant E. coli, although it was the most prevalent in 
previous studies [7, 12, 18, 19]. This observed rate is in 
sharp contrast with the reported low and high detec-
tion rates of 17.4 and 31.8  % in two previous studies 
from China [6, 7]. In the 17 ETEC strains, the est and elt 
genes were detected in 9 and 6 strains, respectively, and 
both est and elt positive were found in two strains. Five 
EIEC strains produced ipaH gene, and the only STEC 
isolate positive for stx1 and eae was O26:K60. The low 
prevalence of STEC and EIEC strains in this study is in 
agreement with the previous studies in China [6, 7] but 
differs from those in Iran and Tunisia, with high isola-
tion rates [12, 20]. As the four most prevalent serovars of 
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Salmonella isolates, Salmonella enteritidis, Salmonella 
typhimurium, Salmonella 1, 4, [5], 12:i:- and Salmonella 
agona represented 32.1, 13.8, 11.9 and 9.2 %, respectively. 
Other isolates belonged to 29 different serotypes, anyone 
of which was present in less than 5  %. Salmonella 1, 4, 
[5], 12:i:-, a monophasic variant of S. typhimurium, has 
increased considerably since the mid-1990s and cur-
rently represents one of the most common serotypes 
causing infection in many countries and Guangdong 
Province in China [21, 22]. As the third most preva-
lent serotype, Salmonella 1, 4, [5], 12:i:- highlighted the 
importance associated with childhood diarrheal disease 
in this study. Of the 37 Shigella isolates, Shigella sonnei 
was the most prevalent species, accounting for 86.5  %. 
Four Shigella flexneri isolates were represented by sero-
types 2a and 4c, and only one Shigella dysenteriae strain 
was detected. The clear predominance of S. sonnei dif-
fers from that found in the studies of other provinces in 
China and many developing countries [6, 7, 12, 23]; how-
ever, several Asian countries have recently experienced 
a transition from S. flexneri to S. sonnei, probably due to 
improvement of overall nutritional status, sanitation and 
socioeconomic status [24–26]. The dominant serotype 
of V. parahaemolyticus was O3:K6, accounting for 80 %. 
Two types of K untypeable (KUT), namely, O1:KUT and 
O3:KUT, accounted for 10 %, respectively.
Prevalence of pathogenic bacteria associated with era, 
season, age and clinical symptoms
Over a period of five consecutive years, the overall iso-
lation rate of enteric bacteria showed a gradual decrease 
from 15.1  % in 2010 to 10.7  % in 2014, with occasional 
Table 1 Demographic and illness characteristics of bacterial pathogens associated with childhood diarrhea in Beijing
a One specimen was identified by mixed infection of EPEC and EAEC, therefore n = 117; SD standard deviation
b Chi square test was calculated by each symptomdue to different pathogen, all significant P values below 0.05 was noted














Age (years), n (%)
 <1 1497 (59.3) 53 (3.5) 44 (2.9) 5 (0.3) 6 (0.4) 107 (7.1)
 1–2 844 (33.4) 58 (6.9) 52 (6.2) 16 (1.9) 4 (0.5) 127 15.0)
 3–4 131 (5.2) 5 (3.8) 11 (8.4) 9 (6.9) 0 (0.0) 25 (19.1)
 =5 52 (2.1) 1 (1.9) 2 (3.8) 7 (13.5) 0 (0.0) 10 (19.2)
 Mean age ± SD 1.2 (1.1) 1.3 (1.0) 1.5 (1.1) 2.9 (1.8) 1.1 (0.7) 1.6 (1.3)
 P value – 0.002 <0.001 <0.001 0.836 <0.001
Sex, n (%)
 Male 1616 (64.0) 70 (4.3) 71 (4.4) 26 (1.6) 3 (0.2) 170 (10.5)
 Female 908 (36.0) 47 (5.2) 38 (4.2) 11 (1.2) 7 (0.8) 99 (10.9)
 P value – 0.333 0.517 0.302 0.025 0.765
Seasons, n (%)
 Spring (Mar–May) 584 (23.1) 22 (3.8) 28 (4.8) 0 (0.0) 1 (0.1) 50 (8.6)
 Summer (Jun–Aug) 1029 (40.8) 62 (6.0) 50 (4.9) 31 (3.0) 6 (0.6) 146 (14.2)
 Autumn (Sep–Nov) 615 (24.4) 27 (4.4) 25 (4.1) 6 (0.9) 3 (0.5) 61 (9.9)
 Winter (Dec–Feb) 296 (11.7) 6 (5.1) 6 (5.1) 0 (0.0) 0 (0.0) 12 (2.0)
 P value – 0.017 0.229 <0.001 0.397 <0.001
Symptom, n (%)
 Fever (>38 °C) 181 (7.2) 3 (2.6)b 21 (19.3)b 14 (37.8)b 0 (0.0) 38 (14.1)b
 Abdominal pain 112 (4.4) 4 (3.4) 8 (7.3) 7 (18.9)b 0 (0.0) 19 (7.1)b
 Vomiting 165 (6.5) 6 (5.1) 5 (4.6) 9 (24.3)b 0 (0.0) 20 (7.4)
 Dehydration 11 (0.4) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 Watery diarrhea 758 (30.0) 38 (32.5) 20 (18.3)b 8 (21.6) 1 (10.0) 66 (24.5)b
 Mucus diarrhea 1724 (68.3) 76 (65.0) 87 (79.8)b 26 (70.3) 8 (80.0) 193 (71.7)
 Bloody diarrhea 63 (2.5) 2 (1.7) 7 (6.4)b 3 (8.1)b 1(10.0) 13 (4.8)b
 Meandiarrhea  
frequency ± SD
4.9 (2.4) 4.3 (2.3) 5.7 (2.6) 6.9 (3.6) 4.1 (1.6) 5.2 (2.8)
 Antibiotic consump-
tion
507 (20.1) 25 (21.4) 28 (25.7) 23 (62.2) 5 (50.0) 79 (29.4)
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interannual variation (Fig.  1). This isolation rate was 
much lower than the reported range of 28.0–55.1  % 
in other works [12, 27], taking into account the varia-
tion pertaining to geographical area, the types of enteric 
pathogens, diagnostic methods and social and educa-
tional conditions. In fact, recent studies have also shown 
lower incidence of infections in economically developed 
regions, such as Shanghai, in China [7, 28] because the 
progress of sanitary conditions has reduced the risk fac-
tors of diarrhea. In this study, different pathogens showed 
various change patterns over time. DEC was identi-
fied (with an isolation rate of 4.6 %) as the most preva-
lent pathogen, with an increased trend during the past 
5  years. Salmonella, with an isolation rate of 4.3  %, has 
remained fairly constant in the past decade in China 
[5, 7, 21, 29, 30] but is much higher than in Bangladesh 
(0.78  %) [31] and lower than in Brazil (38.4  %) [9]. The 
present study also showed a significant decrease in diar-
rhea caused by Shigella (1.4 %) and V. parahaemolyticus 
(0.4 %). Although these results were consistent with mul-
ticenter data throughout China [6, 7], due to the limited 
data covering only a few years, it could not be estab-
lished whether this trend will be maintained or vary in 
subsequent years. Further studies in the same area are 
necessary to definitively confirm these trends and to 
verify whether they truly correspond to an epidemiologic 
change or are just a response to exceptional situations.
The etiologic bacteria were isolated throughout the 
year, with a seasonal peak in summer (June–August) 
(Fig. 1; Table 1), which was also observed in other stud-
ies and is strongly associated with environmental fac-
tors [32], such as ambient temperature, precipitation 
and humidity. Beijing, with a high population density, 
is located in Northeastern China in the northern warm 
zone. In summer, the hot and humid climate facilitates 
microbial breeding, and food is more vulnerable to bac-
terial contamination, which may influence the survival 
and transmission of pathogens. This study showed that 
Shigella-caused diarrhea had a distinct peak in August. 
V. parahaemolyticus prevalence presented no remarkable 
seasonal trend because of the limited number of isolates. 
Salmonella and DEC were detected throughout the year 
with seasonal fluctuation.
The prevalence of pathogen categories was corre-
lated with outpatient age (Table 1). The proportion of all 
causative bacteria was highest in children aged 3–5 years 
(19.1  %, P  <  0.001). Shigella infection was the highest 
in the age group of 5  years (13.5  %, P  <  0.001). Salmo-
nella-caused diarrhea was most common at the age of 
3–4 years (8.4 %, P < 0.001), whereas DEC infection in the 
group of 3–4  years (3.8  %) was secondary to the group 
of 1–2  years (6.9  %) (P  =  0.002). V. parahaemolyticus 
showed no variation with age. Therefore, continuous sur-
veillance targeting high-risk groups is needed to monitor 
the variation of etiology and epidemiological features.
The prevalence of clinical symptoms was also correlated 
with the distribution of pathogen categories (Table  1). 
Fever was the most common in all bacterial infections, 
except V. parahaemolyticus (P < 0.001). Abdominal pain 
and vomiting were the highest in Shigella infection (18.9 
Table 2 Distribution of  different enteropathogenic 
bacteria(n = 274) isolated from diarrheal patients
a The serotype of STEC is O26:K60
b The sum of the other serotypes excluding the top 8 serotypeslisted above
Any simple pathogen No. of isolates (%)
Diarrheagenic E.coli (n = 118, 5 serogroups) 118 (43.1)
 EPEC
  Atypical (eae+ , bfpA−) 58 (49.2)
  Typical (eae+ , bfpA +) 9 (7.6)
 EAEC
  aggR+ 28 (23.7)
 ETEC
  est+ 9 (7.6)
  elt+ 6 (5.1)
  Both+ 2 (1.7)
 EIEC (ipaH +) 5(4.2)
 STEC (eae + , stx1 +)a 1 (0.8)
Salmonella spp. (n = 109, 33 serotypes) 109 (39.8)
 S. enteritidis 35 (32.1)
 S. typhimurium 15 (13.8)
 Salmonella 1, 4, [5], 12:i:- 13 (11.9)
 S. agona 10 (9.2)
 S. paratyphi C 4 (3.7)
 S. infantis 3 (2.8)
 S. braenderup 2 (1.8)
 S. tennessee 2 (1.8)
 Other serotypesb 25 (22.5)
Shigella spp. (n = 37, 4 serotypes) 37 (13.5)
 S. sonnei 32 (86.5)
 S. flexneri 2a 2 (5.4)
 S. flexneri 4c 2 (5.4)
 S. dysenteriae 2 1 (2.7)
V. parahaemolyticus (n = 10, 3 serotypes) 10 (3.6)
 V. parahaemolyticus O3:K6 8 (80)
 V. parahaemolyticus O3:KUT 1 (10)
 V. parahaemolyticus O1:KUT 1 (10)
Total 274 (100)
Mixed infections (n = 5)
 EPEC/Salmonella (S. enteritidis) 1
 EPEC/Salmonella (S. infantis) 1
 EAEC/Salmonella (S. typhimurium) 1
 EPEC/Shigella (S. sonnei) 1
 EPEC/EAEC 1
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and 24.3  %, respectively, P  <  0.001). Salmonella infec-
tion caused mucus stool, watery stool and bloody stool 
in 79.8, 18.3 and 6.4 % of cases, respectively (all P < 0.05), 
whereas Shigella infection was significantly associated 
with only bloody stool (8.1 %, P = 0.024).
Antimicrobial resistance of Salmonella and Shigella
Antimicrobial drug testing was performed on 109 Salmo-
nella isolates and 37 Shigella isolates (Table  3). For the 
Salmonella isolates, resistance to nalidixic acid (NAL) 
was most common (56.0  %), followed by resistance to 
sulfisoxazole (SUL) (55.0 %), ampicillin (AMP) (46.8 %), 
streptomycin (STR) (44.0 %), tetracycline (TET) (29.4 %) 
and chloramphenicol (CHL) (16.5 %). The resistance pro-
files differed among different serotypes. S. typhimurium 
and Salmonella 1, 4, [5], 12:i:- isolates showed signifi-
cantly higher resistance to most antibiotics than S. ente-
ritidis isolates, similarly to previous studies [6, 21, 33]. 
Overall, the resistance of other serotypes was relatively 
lower than that of the top three dominant serotypes. 
Approximately 50  % of Salmonella isolates were resist-
ant to at least three antimicrobials, 41.3  % were resist-
ant to four, 22.9 % were resistant to five and 12.8 % were 
resistant to six. Many different patterns of resistance 
were observed with two predominant resistance patterns: 
AMP-STR-SUL-TET (n = 7, 6.4 %) and AMP-STR-SUL-
NAL (n = 6, 5.5 %).
The resistance of Shigella to nearly all antimicrobi-
als was much more obvious than Salmonella, except 
CHL and ciprofloxacin (CIP). Of the 37 Shigella isolates, 
resistance to STR was most common (100 %), followed by 
resistance to NAL (97.3 %), AMP (94.6 %), SUL (91.9 %) 
and gentamicin (GEN) (81.1  %). Moderate resistance 
to TET (45.9  %) and ceftriaxone (CRO) (29.7  %) was 
also observed; however, resistance to CHL and CIP was 
relatively low (16.2 and 2.7  %, respectively). All Shigella 
isolates were resistant to at least three antimicrobials, 
94.6 % of isolates were resistant to four or five antimicro-
bials and 56.8 % were resistant to six. The two dominant 
antimicrobial resistant profiles were AMP-GEN-NAL-
STR-SUL (n  =  12, 32.4  %) and AMP-GEN-NAL-STR-
SUL-TET (n = 8, 21.6 %). S. sonnei isolates were resistant 
to five (96.9 %) and six (56.3 %) antimicrobials, and of the 
four S. flexneri isolates, 100 and 75 %, respectively, were 
resistant to five and six antimicrobials. Although a simi-
lar pattern of resistance was reported in China and other 
Asian countries [6, 34, 35], the frequency of resistance 
reported here is higher, and the trend of multidrug resist-
ance is more pronounced.
According to the WHO guidelines for the treatment 
of diarrhea, antimicrobials should not be used routinely, 
particularly for unknown causative agents. Antimicro-
bials are reliably helpful only for children with bloody 
diarrhea (probable shigellosis), suspected cholera with 
severe dehydration and serious non-intestinal infec-
tions, such as pneumonia [36]. Because the proportion 
of isolates resistant to AMP, CHL, SUL, STR, GEN and 
TET has increased substantially among Shigella isolates 
worldwide in the past decade, these drugs are no longer 
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Fig. 1 Isolated rate of enteropathogens per month in Beijing during 2010–2014
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the WHO. Cephalosporins and fluoroquinolones are 
two popular acceptable options to treat severe gastro-
intestinal infections caused by pathogenic bacteria. As 
the third generation of the above two kinds of antibiot-
ics, CRO and CIP are the drugs of choice for all patients 
with bloody diarrhea according to the WHO, irrespec-
tive age [36]. However, the 9.3 and 29.7 % prevalence of 
resistance to CRO in Salmonella and Shigella isolates 
from diarrheal children was noteworthy in Beijing. 
Additionally, our study showed, respectively, 9.2 and 
2.7 % resistance rates to CIP in Salmonella and Shigella 
isolates, which is an alarming development that may 
also exist in other regions, such as Shanghai and Anhui 
in China [37, 38].
Antibiotic use outside hospitals without a medical pre-
scription is very common, and most patients (65 %) with 
a diarrheal illness in China are treated with antibiotics 
without identification of the causative pathogen [39]. In 
this study, 20.1 % of children had taken antibiotics prior 
to admission, whereas only 2.5  % had bloody diarrhea. 
The widespread use of antimicrobial agents in the treat-
ment of infections is responsible for the alarming rate of 
increase of multiple antimicrobial resistance and poses a 
great challenge. Serious constraints should be imposed 
on the antibiotics available for treatment of diarrhea 
among pediatricians. Even for therapy, antimicrobial 
treatment strategies must be designed to ensure safety 
and efficacy based on current resistance patterns.
Conclusion
The current surveillance system can identify only the 
common bacterial pathogens without understanding the 
patterns of viral and parasitic infection, which should be 
included to make the findings of the study more com-
plete and valuable. To date, we can characterize only the 
resistance patterns for Salmonella and Shigella. As the 
active surveillance continues, we will further explore the 
etiologic spectrum and variation trends in antimicro-
bial resistance so that we can execute earlier and proper 
intervention to decrease the financial load on the patient 
and on health care.
Methods
Study design and population
The active surveillance program, the Enterobacte-
rial Communicable Disease Surveillance (ECDS), was 
conducted from April 2010 to December 2014 in Bei-
jing, the capital of China. Seventeen sentinel hospitals 
affiliated with six districts with different geographical 
and socioeconomic situation enrolled outpatients with 
acute diarrhea on two random days per week. A total 
of 2524 children under 5  years of age who were admit-
ted with acute diarrhea diseases were included in this 
study. Clinical examination of each patient by a physi-
cian was followed by treatment and monitoring. The 
clinical and epidemiological information was recorded 
through the electronic gastrointestinal clinic surveillance 
Table 3 Antimicrobial resistance among Salmonella and Shigella isolates by serovars
For 109 Salmonella isolates, two dominant resistance patterns are AMP-STR-SUL-TET (n = 7, 6.4 %) and AMP-STR-SUL-NAL (n = 6, 5.5 %)
For 37 Shigella isolates, two dominant resistant patternsare AMP-GEN-NAL-STR-SUL (n = 12, 32.4 %) and AMP-GEN-NAL-STR-SUL-TET (n = 8, 21.6 %)
AMP ampicillin, CRO ceftriaxone, CIP ciprofloxacin, NAL nalidixic acid, TET tetracycline, GEN gentamicin, CHL chloramphenicol, SUL sulfisoxazole, STR streptomycin, 
MDR3 resistance to any three antibiotics, MDR4 resistance to any four antibiotics and so on
Antimicro-
bial





















AMP 21 (60.0) 12 (80.0) 11 (84.6) 1 (10.0) 51 (46.8) 31 (96.9) 4 (100.0) 0 (0.0) 35 (94.6)
CHL 3 (8.6) 8 (53.3) 4 (30.8) 1 (10.0) 18 (16.5) 2 (6.3) 4 (100.0) 0 (0.0) 6 (16.2)
CIP 1 (2.9) 6 (40.0) 3 (23.1) 0 (0.0) 10 (9.2) 0 (0.0) 1 (25.0) 0 (0.0) 1 (2.7)
CRO 7 (20.0) 0 (0.0) 2 (15.4) 0 (0.0) 10 (9.2) 10 (31.3) 1 (25.0) 0 (0.0) 11 (29.7)
GEN 3 (8.6) 7 (46.7) 3 (23.1) 1 (10.0) 14 (12.8) 30 (93.8) 0 (0.0) 0 (0.0) 30 (81.1)
NAL 34 (97.1) 9 (60.0) 5 (38.5) 1 (10.0) 61 (56.0) 32 (100.0) 4 (100.0) 0 (0.0) 36 (97.3)
STR 15 (42.9) 10 (66.7) 12 (92.3) 2 (20.0) 48 (44.0) 32 (100.0) 4 (100.0) 1 (100.0) 37 (100.0)
SUL 19 (54.3) 12 (80.0) 9 (69.2) 2 (20.0) 60 (55.0) 32 (100.0) 1 (25.0) 1 (100.0) 34 (91.9)
TET 7 (20.0) 10 (66.7) 10 (76.9) 1 (10.0) 32 (29.4) 12 (37.5) 4 (100.0) 1 (100.0) 17 (45.9)
Multidrug-resistance (MDR)
 MDR3 22 (62.9) 12 (80.0) 11 (84.6) 1 (10.0) 54 (50.0) 32 (100) 4 (100.0) 1 (100) 37 (100)
 MDR4 17 (48.6) 12 (80.0) 9 (69.2) 1 (10.0) 45 (41.3) 31 (96.9) 4 (100.0) 0 (0.0) 35 (94.6)
 MDR5 7 (20.0) 10 (66.7) 5 (38.5) 1 (10.0) 25 (22.9) 31 (96.9) 4 (100.0) 0 (0.0) 35 (94.6)
 MDR6 2 (5.7) 7 (46.7) 4 (30.8) 1 (10.0) 14 (12.8) 18 (56.3) 3 (75.0) 0 (0.0) 21 (56.8)
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and reporting system. Enrollment was subject to obtain-
ing informed verbal consent from the parent or guardian 
who accompanied the child. All specimens were collected 
on the day of presentation by rectal swabs in Cary-Blair 
transport media and were immediately transported to 
the laboratory of Disease Prevention and Control (CDC) 
for processing within 24 h.
Detection of bacteria
All specimens were processed by routine microbiologic 
and biochemical tests to identify different enteropatho-
genic bacteria. Each stool specimen was cultured by 
streaking on xylose-lysine deoxycholate (XLD) agar and 
Salmonella-Shigella agar (Becton–Dickinson Co., Sparks, 
MD, USA) for Shigella spp., and Salmonella spp., respec-
tively, and incubating at 37  °C for 16–24 h. For S. typhi, 
swabs were enriched in Selenite brilliant-green broth 
(Becton–Dickinson Co., Sparks, MD, USA) at 37 °C over-
night, followed by sub-culturing on the media described 
above. For selective enrichment of Vibrio spp., swabs were 
inoculated on peptone water containing 3 % NaCl, pH 8, 
were incubated at 37 °C overnight, inoculated on CHRO-
Magar Vibrio media (CHROMagar Co., Paris, France), 
and incubated for 16–24  h. After culturing, at least five 
colonies morphologically resembling specific species were 
selected for further identification by biochemical testing 
according to standard methods. For other enteropatho-
genic bacteria, the systematic identification was con-
firmed with a VITEK 2 Compact instrument (bioMérieux, 
Marcyl’Etoile, France). Finally, serotyping was performed 
by slide agglutination test using commercially avail-
able antisera (Salmonella antisera from State Serum SSI 
Diagnostica, Denmark, Shigella and Vibrio antisera from 
Denka Seiken, Tokyo, Japan).
Real-time PCR assay for diarrheagenic E. coli
Pathotypes of DEC were identified by real-time PCR, 
including EAEC, EIEC, EPEC, ETEC and STEC. E. coli-
like and other gram-negative colonies growing on Mac-
Conkey agar were tested for the presence of virulence 
genes using seven sets of primers targeting aggR, stx1, 
stx2, ipaH, bfpA, eae, elt and est (Additional file 1). The 
real-time PCR assay was performed using the TaqMan® 
Universal PCR Master Mix Kit (Applied Biosystems, 
USA) on an Applied Biosystems 7500 Real-Time PCR 
System. The reaction mixture consisted of 2X PCR Mas-
ter Mix, 200  nM of forward and reverse primers, and 
200 nM of TaqMan probe. The amplification profile con-
sisted of heat activation at 95 °C for 10 min; 40 cycles of 
denaturation at 95 °C for 15 s, annealing, extension, and 
fluorogenic signal detection at 60 °C for 1 min. The assay 
was considered positive when the number of cycles to 
detection was 35 or less with the standard S curve.
Antimicrobial susceptibility testing
The antibiotic resistance of the bacterial isolates was 
tested using the Kirby-Bauer disk diffusion method fol-
lowing the guidelines of the Clinical and Laboratory 
Standards  Institute (CLSI 2010). E. coli (ATCC 25922) 
was included in the test for quality control. The disk con-
centrations of 9 antimicrobial agents (Oxide, UK) were as 
follows: 10  μg AMP, 30  μg CRO, 5  μg CIP, 30  μg NAL, 
30  μg TET, 10  μg GEN, 30  μg CHL, 300  μg SUL, and 
10  μg STR. Multidrug resistance was defined as resist-
ance to at least three classes of antibiotics.
Statistical analysis
All data were entered in an Excel database (Additional 
file  2) (Microsoft Corporation, USA). Statistical analysis 
was performed with SPSS/11.5 software (SPSS Inc., USA). 
Comparison of proportions and statistical significance 
were calculated using a two-tailed Chi square test or Fish-
er’s exact test with a P < 0.05 considered significant.
Abbrevations
DEC: diarrheagenic Escherichia coli; EPEC: enteropathogenic Escherichia coli; 
EAEC: enteroaggregative Escherichia coli; ETEC: enterotoxigenic Escherichia coli; 
EIEC: enteroinvasive Escherichia coli; STEC: shiga toxin-producing Escherichia 
coli; KUT: Kuntypeable; NAL: nalidixic acid; SUL: sulfisoxazole; AMP: ampicillin; 
STR: streptomycin; TET: tetracycline; CHL: chloramphenicol; CIP: ciprofloxa-
cin; GEN: gentamicin; CRO: ceftriaxone; MDR: multidrug-resistance; ECDS: 
enterobacterial communicable disease surveillance; CDC: disease prevention 
and control; XLD: xylose-lysine deoxycholate; CLSI: Clinical and Laboratory 
Standards Institute.
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